MarketsmithIndia Articles

Nifty Continues to Trade in Narrow Range; Pharma Stocks Outperform This Week

Author: Rushit Sejpal

Posted Date: July 02 2021
Weekly Action

Nifty, -0.9%; Sensex, -0.8%; Nifty Midcap, +0.5%; Nifty Smallcap, +2.2%; Model Portfolio, +3.4%.

Market Pulse: Confirmed Uptrend

Distribution Day CountFour

Weekly Market Review

Nifty traded in the range of 15,636–15,915 this week. It was volatile, but the range was narrow and volume was low. It closed lower in four out of five sessions. One distribution day was added on Tuesday. Nifty breached its 21-DMA on Wednesday, but traded very close to it and did not fall further. The trend during all sessions was similar during the week. Nifty opened either flat or positive and shed its gains before the session ended. However, there was some last-hour buying today, which helped Nifty close in the positive zone. On a weekly basis, barring Nifty Pharma (+3.3%) and FMCG (+0.6%), all sectoral indices closed lower. Nifty Bank, Metal, and Financial Services closed 1.5–1.8% lower.

Today, barring Nifty Metal (-1.6%), all sectoral indices closed flat or positive. Nifty Bank, Financial Services, Pharma, and Realty closed 0.2–0.6% higher, while Nifty Auto, FMCG, and IT closed flat. The broader market outperformed the benchmark indices. Today, the advance-decline ratio was in favor of advancers. Of the 2,285 stocks traded, 1,134 advanced, 775 declined, and the rest remained unchanged.

The distribution day count is currently elevated to four. If the index falls further, adds a couple of distribution days, and breaches its key moving averages, we may change the market status to an Uptrend Under Pressure. We continue to recommend a selective approach to increasing risk. Focus on quality ideas emerging out of sound bases with RS line at or near new highs while reducing exposure to stocks breaking below key support levels.

Key News

What do you think? Please email us any questions or comments.

Disclaimer: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. It is for educational purposes only.For more information, see our Legal disclosures here.

Related Article